NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.8489
-0.0034 (-0.40%)
At close: Jan 5, 2026, 4:00 PM EST
0.8701
+0.0212 (2.50%)
After-hours: Jan 5, 2026, 5:45 PM EST
NMTC Revenue
NeuroOne Medical Technologies had revenue of $1.70M in the quarter ending June 30, 2025, with 105.39% growth. This brings the company's revenue in the last twelve months to $6.63M, up 69.00% year-over-year. In the fiscal year ending September 30, 2024, NeuroOne Medical Technologies had annual revenue of $3.45M with 1.33% growth.
Revenue (ttm)
$6.63M
Revenue Growth
+69.00%
P/S Ratio
2.82
Revenue / Employee
$672,094
Employees
18
Market Cap
42.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 3.45M | 45.37K | 1.33% |
| Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
| Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
| Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
| Sep 30, 2020 | 1.93M | - | - |
| Sep 30, 2019 | - | - | - |
| Sep 30, 2018 | - | - | - |
| Jun 30, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | 773.00 | -476.00 | -38.11% |
| Dec 31, 2013 | 1.25K | 328.00 | 35.61% |
| Dec 31, 2012 | 921.00 | -4.48K | -82.94% |
| Dec 31, 2011 | 5.40K | 4.23K | 362.55% |
| Dec 31, 2010 | 1.17K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NMTC News
- 19 days ago - NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - NeuroOne Medical Technologies Corporation - Special Call - Seeking Alpha
- 4 months ago - NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025 - GlobeNewsWire
- 5 months ago - NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain - GlobeNewsWire
- 5 months ago - NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9% - GlobeNewsWire
- 5 months ago - NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update - GlobeNewsWire
- 5 months ago - NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - GlobeNewsWire